Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Subsea 7 S.A. SUBCY: This company that delivers offshore projects and services for the energy sector has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 17% over the last 60 days.
Subsea 7 SA Price and Consensus
Subsea 7 SA price-consensus-chart | Subsea 7 SA Quote
MAG Silver Corp. MAG: This precious metal company has seen the Zacks Consensus Estimate for its current year earnings increasing 18.3% over the last 60 days.
MAG Silver Corporation Price and Consensus
MAG Silver Corporation price-consensus-chart | MAG Silver Corporation Quote
Karooooo Ltd. KARO: This company that provides mobility software-as-a-service (SaaS) platform for connected vehicles has seen the Zacks Consensus Estimate for its current year earnings increasing nearly 7% over the last 60 days.
Karooooo Ltd. Price and Consensus
Karooooo Ltd. price-consensus-chart | Karooooo Ltd. Quote
Candel Therapeutics, Inc. CADL: This clinical stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 17.9% over the last 60 days.
Candel Therapeutics, Inc. Price and Consensus
Candel Therapeutics, Inc. price-consensus-chart | Candel Therapeutics, Inc. Quote
Popular, Inc. BPOP: This retail, mortgage, and commercial banking products and services company has seen the Zacks Consensus Estimate for its current year earnings increasing 4.8% over the last 60 days.
Popular, Inc. Price and Consensus
Popular, Inc. price-consensus-chart | Popular, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Popular, Inc. (BPOP): Free Stock Analysis Report Subsea 7 SA (SUBCY): Free Stock Analysis Report MAG Silver Corporation (MAG): Free Stock Analysis Report Karooooo Ltd. (KARO): Free Stock Analysis Report Candel Therapeutics, Inc. (CADL): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research